|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 111, Issue 2 249-260, Copyright © 1998 by Company of Biologists
JOURNAL ARTICLES |
JO Gonatas, YJ Chen, A Stieber, Z Mourelatos and NK Gonatas
Department of Pathology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. Gonatas@pobox.upenn.edu
MG160, a type I cysteine-rich membrane sialoglycoprotein residing in the medial cisternae of the rat Golgi apparatus, is highly homologous to CFR, a fibroblast growth factor receptor, and ESL-1, an E-selectin ligand located at the cell surface of mouse myeloid cells and recently detected in the Golgi apparatus as well. The mechanism for the transport of MG160 from the Golgi apparatus to the cell surface is unknown. In this study we found that differential processing of the carboxy-terminal cytoplasmic domain (CD), consisting of amino acids Arg1159 Ile Thr Lys Arg Val Thr Arg Glu Leu Lys Asp Arg1171, resulted in the partial transport of the protein to the plasma membrane and filopodia. In Chinese hamster ovary cells (CHO), stably transfected with the entire cDNA encoding MG160, the protein was localized in the Golgi apparatus. However, when the terminal Arg1171 or up to nine distal amino acids were deleted, the protein was distributed to the plasma membrane and filopodia as well as the Golgi apparatus. This report shows that the CD of an endogenous type I Golgi protein is important for its efficient retention and identifies a unique residue preference in this process. Cleavage within the CD of MG160 may constitute a regulatory mechanism for the partial export of the protein from the Golgi apparatus to the plasma membrane and filopodia.
This article has been cited by other articles:
![]() |
J. Ahn, M. Febbraio, and R. L. Silverstein A novel isoform of human Golgi complex-localized glycoprotein-1 (also known as E-selectin ligand-1, MG-160 and cysteine-rich fibroblast growth factor receptor) targets differential subcellular localization J. Cell Sci., April 15, 2005; 118(8): 1725 - 1731. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Strey, D. Spellman, A. Stieber, J. O. Gonatas, X. Wang, J. D. Lambris, and N. K. Gonatas Dysregulation of Stathmin, a Microtubule-Destabilizing Protein, and Up-Regulation of Hsp25, Hsp27, and the Antioxidant Peroxiredoxin 6 in a Mouse Model of Familial Amyotrophic Lateral Sclerosis Am. J. Pathol., November 1, 2004; 165(5): 1701 - 1718. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brandlein, I. Beyer, M. Eck, W. Bernhardt, F. Hensel, H. K. Muller-Hermelink, and H. P. Vollmers Cysteine-rich Fibroblast Growth Factor Receptor 1, a New Marker for Precancerous Epithelial Lesions Defined by the Human Monoclonal Antibody PAM-1 Cancer Res., May 1, 2003; 63(9): 2052 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Milland, S. M. Russell, H. C. Dodson, I. F. C. McKenzie, and M. S. Sandrin The Cytoplasmic Tail of alpha 1,3-Galactosyltransferase Inhibits Golgi Localization of the Full-length Enzyme J. Biol. Chem., March 15, 2002; 277(12): 10374 - 10378. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Bell, M. A. Ward, W. P. Blackstock, H. N. M. Freeman, J. S. Choudhary, A. P. Lewis, D. Chotai, A. Fazel, J. N. Gushue, J. Paiement, et al. Proteomics Characterization of Abundant Golgi Membrane Proteins J. Biol. Chem., February 9, 2001; 276(7): 5152 - 5165. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Milland, S. G. Taylor, H. C. Dodson, I. F. C. McKenzie, and M. S. Sandrin The Cytoplasmic Tail of alpha 1,2-Fucosyltransferase Contains a Sequence for Golgi Localization J. Biol. Chem., April 6, 2001; 276(15): 12012 - 12018. [Abstract] [Full Text] [PDF] |
||||